MoSys Announces Oricane Support of Custom Algorithm

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MoSys Announces Oricane Support of Custom Algorithm Development for Its Programmable Search Engine to Accelerate Cloud Infrastructure, Security, and Processing Solutions

SANTA CLARA, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- MoSys (NASDAQ:MOSY), a leader in semiconductor solutions that enable fast, intelligent data access for Cloud, network, and communications systems, today announced that Oricane will partner with MoSys to support developments on the MoSys® Programmable Search Engine platform. Oricane has developed a family of network search algorithms, including code and management software called BioCAM® Search. The algorithms and software can be customized and optimized to customer requirements on a MoSys Bandwidth Engine® (BE) or Programmable Search Engine (PSE) platform to deliver differentiated networking search or data processing solutions for Cloud infrastructure applications such as SDN, NFV, load balancing, processor offload or security.

The MoSys PSE is a monolithic IC designed for packet processor offload that leverages 32 search-optimized processing engines, data access schedulers, and over one and a half terabits of internal access bandwidth. The device combines MoSys’ proven serial interface technology and high-density integrated memory with the processor engine architecture. Paired with FPGAs or network processors, the PSE or BE platforms deliver a compelling solution for customized high-performance packet processing and analytics applications. 

The Oricane BioCAM Search algorithm and software accelerates classification and forwarding of Internet traffic functions, such as longest prefix matching and multiple field classification, providing a high-speed, high-density search solution. Together with MoSys’ PSE and BE platforms, BioCAM Search algorithms and software provide an innovative alternative to TCAMs and other traditional memory architectures while enabling new capabilities.  

BioCAM Search can transform the PSE into a high-speed and high-density alternative to TCAMs with native support for IPv4/IPv6 Longest Prefix Matching (LPM) and IPv4/IPv6 Multiple Field Classification (MFC) for ACL/SDN type applications. Taking advantage of the 1Gb table capacity of the PSE, the BioCAM Search algorithms can support table sizes in the range of 8 to 16 million prefixes and ACL rule sets of 1 million. With size and performance tradeoff flexibility, the combination can yield capacity that is up to 4x larger than a TCAM and support packet processors with aggregate packet rates up to 400Gbps and search requirements as high as 1Bsps.

“MoSys’ Programmable Search Engine and Bandwidth Engine architectures enable a unique combination of performance and flexibility,” stated Mikael Sundström, CEO for Oricane. “Adding our proven BioCAM Search algorithms and software enables a flexible industry-leading search and data processing engine.”

“The Cloud requires performance and flexible programming of networking functions and processor offloads to support a dynamic infrastructure with low capex and opex,” stated John Monson, VP of marketing and sales for MoSys. “The performance and flexibility of the PSE architecture combined with software solutions, such as Oricane’s, enables OEMs and network operators to deliver configurable platforms capable of supporting terabits per second.”

MoSys supports an integrated development environment (IDE) to support code development for its PSE and PSE models to validate functionality prior to integration. In addition, evaluation boards based on FMC have been developed to plug into standard FPGA platforms.  

MoSys BE and PSE devices and platforms, as well as Oricane BioCAM software, are available today. Customers interested in getting started on development of a custom search solution can contact either company.

About MoSys, Inc.
MoSys, Inc. (NASDAQ:MOSY) is a fabless semiconductor company enabling leading equipment manufacturers of Cloud, networking, communications, and data center systems to address the continual increase in Internet users, data and services. The company's solutions deliver data path connectivity, speed and intelligence while eliminating data access bottlenecks on line cards and systems scaling from 100G to multi-terabits per second. Engineered and built for high-reliability carrier and enterprise applications, MoSys' Bandwidth Engine®, Programmable Search Engine, and LineSpeed™ IC product families are based on the company's patented high-performance, high-density intelligent access and high-speed serial interface technology, and utilize the company's highly efficient GigaChip® Interface. MoSys is headquartered in Santa Clara, California. More information is available at www.mosys.com.

About Oricane
Founded in 2006, Oricane is the provider of the BioCAM® family of algorithm-based solutions for accelerating classification and forwarding of Internet traffic, addressing the future performance requirements for the next generation networking equipment. Oricane collaborates with leading fabless semiconductor vendors to bring future-proof embedded and stand-alone Network Search Engines (NSEs) to the market, embracing the rapid development in Software Defined Networks (SDNs) and Network Functions Virtualization (NFV) thereby driving the acceleration of number of connected devices – The Internet of Things – throughout the 21st century.

Bandwidth Engine, GigaChip, and MoSys are registered trademarks of MoSys, Inc. in the US and/or other countries. LineSpeed and the MoSys logo are trademarks of MoSys, Inc. All other marks mentioned herein are the property of their respective owners.

Contacts: Kristine Perham MoSys, Inc. +1 (408) 418-7670 kperham@mosys.com Beverly Twing, Sr. Acct. Manager Shelton Group, Investor Relations +1 (214) 272-0089 btwing@sheltongroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 201

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 155

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 119

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 65

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading

Top 5 Most Recently Viewed Articles

How MENU ORDER AI is Transforming Dining for GLP-1 Users

Updated Category News Views 391

MENU ORDER AI: The Future of Dining for GLP-1 Users As a unique health-tech application tailored for GLP-1 users, MENU ORDER AI is pioneering a dining revolution. Designed to assist both diners and restaurants, this amazing application utilizes AI to scan menus in real-time and provide nutritional insights. It empowers users to 'Eat anywhere. Order smarter.' Medicare...

Continue Reading
Advancements in MPYS Protein Stimulants: A Comprehensive Overview

Updated Category News Views 258

Innovations in MPYS Protein Stimulants MPYS protein stimulants are making waves in the field of immunotherapy, revolutionizing the way we combat various diseases including cancers and autoimmune disorders. These stimulants activate the STING pathway, significantly enhancing the body’s innate immune response to infections and malignancies. With a growing demand for...

Continue Reading
Discover RoboUP's Revolutionary TM01 Series 2025 Mower

Updated Category News Views 244

RoboUP Unveils the TM01 Series 2025: A New Era in Lawn Care As a prominent name in robotic lawn care technology, RoboUP has introduced its groundbreaking TM01 Series 2025 mower, aimed at addressing the commonly faced challenges in traditional lawn maintenance. With a focus on user-friendly features, RoboUP is setting a remarkable benchmark in the world of automated...

Continue Reading
IMAX: A Hidden Gem in the Entertainment Sector for 2025

Updated Category News Views 181

IMAX's Impressive Performance in 2025 While many investors have focused on the explosive growth of artificial intelligence stocks in 2025, one company in the entertainment technology arena has maintained remarkable performance, largely unnoticed. IMAX Corporation (NYSE: IMAX) has achieved significant returns, boasting an impressive year-to-date increase of over 41%. This...

Continue Reading
Experience Monster Jam Excitement with Northern Tool in Houston

Updated Category News Views 81

Exciting Collaboration Between Northern Tool + Equipment and Monster Jam Northern Tool + Equipment is thrilled to bring the legendary Monster Jam experience to the Houston-area community. This special event will feature an iconic Monster Jam truck, providing fans with an opportunity to see the high-powered vehicle up close. Event Details and Exclusive Offers The...

Continue Reading